(Q35170909)

6 August 2017

1 reference

title

Cell-cycle control of plasma cell differentiation and tumorigenesis (English)

1 reference

6 August 2017

1 reference

Selina Chen-Kiang

1

1 reference

6 August 2017

publication date

1 August 2003

1 reference

6 August 2017

published in

Immunological Reviews

1 reference

6 August 2017

volume

194

1 reference

6 August 2017

page(s)

39-47

1 reference

The extent of affinity maturation differs between the memory and antibody-forming cell compartments in the primary immune response

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Death receptors: signaling and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

TRAIL/Apo-2 ligand induces primary plasma cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Interleukin-6 regulates expression of the syndecan-1 proteoglycan on B lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Lifetime of plasma cells in the bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Humoral immunity due to long-lived plasma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Identification and characterization of a new member of the TNF family that induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

The retinoblastoma protein and cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Role of cyclin A and p27 in anti-IgM induced G1 growth arrest of murine B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

CD40-mediated induction of p21 accumulation in resting and cycling B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

An important role of CDK inhibitor p18(INK4c) in modulating antigen receptor-mediated T cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

p21 is a universal inhibitor of cyclin kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Short-lived and long-lived bone marrow plasma cells are derived from a novel precursor population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

BLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Plasma cell differentiation requires the transcription factor XBP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Impaired immune and acute-phase responses in interleukin-6-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Haploinsufficiency of p18(INK4c) sensitizes mice to carcinogen-induced tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Frequent inactivation of the cyclin-dependent kinase inhibitor p18 by homozygous deletion in multiple myeloma cell lines: ectopic p18 expression inhibits growth and induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Methylation of the p16INK4A gene in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Cyclin D3 Compensates for Loss of Cyclin D2 in Mouse B-lymphocytes Activated via the Antigen Receptor and CD40

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

Sequential interaction of the chaperones BiP and GRP94 with immunoglobulin chains in the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. III. The kinetics of V region mutation and selection in germinal center B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

7 January 2021

Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

7 January 2021

Immunological memory and protective immunity: understanding their relation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

7 January 2021

B lymphocytes express and lose syndecan at specific stages of differentiation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

7 January 2021

Distinct short-lived and long-lived antibody-producing cell populations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

7 January 2021

CDK inhibitors: positive and negative regulators of G1-phase progression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

7 January 2021

Differential modulation of cyclin-dependent kinase inhibitor p27Kip1 by negative signaling via the antigen receptor of B cells and positive signaling via CD40.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

7 January 2021

Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

7 January 2021

Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

7 January 2021

Reversal of EBV immortalization precedes apoptosis in IL-6-induced human B cell terminal differentiation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

7 January 2021

Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

7 January 2021

The expression of p18INK4 and p27kip1 cyclin-dependent kinase inhibitors is regulated differently during human B cell differentiation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

7 January 2021

CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

7 January 2021

CDK inhibitor p18(INK4c) is required for the generation of functional plasma cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

7 January 2021

INK4d-deficient mice are fertile despite testicular atrophy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

7 January 2021

A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

7 January 2021

Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

7 January 2021

Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

7 January 2021

A new member of the leucine zipper class of proteins that binds to the HLA DR alpha promoter

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

7 January 2021

The role of interleukin-6 in mucosal IgA antibody responses in vivo

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

7 January 2021

Analysis of the p16INK4A, p15INK4B and p18INK4C genes in multiple myeloma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00065.X

7 January 2021

10.1034/J.1600-065X.2003.00065.X

Identifiers

DOI

1 reference

6 August 2017

1 reference